A research study titled, “Insulin
Patch Pump Market by Type and Application - Global Industry Analysis and
Forecast to 2025” published by Crystal Market Research, states that Insulin
Patch Pump Market is expected to witness significant growth by 2025.
Diabetes
is a chronic disease which occurs either when the pancreas fails to develop
sufficient insulin or when the human body is unable to effectively use the
insulin. Symptoms associated with diabetes are frequent urination, blurred
vision, increased thirst, rapid weight loss, numbness or tingling sensation in
hands or feet and increased hunger. Factors which escalate the risk of diabetes
are family history, ethnicity, physical inactivity, unhealthy diet, and
smoking. Diabetes can damage the heart, eyes, blood vessels, kidneys, and
nerves which may lead to disability and premature death. There are three types
of diabetes, namely, type 1, type 2, and gestational diabetes. Type 1 diabetes
can cause because of complex interaction between genes and environmental
factors. The most common risk factors for type 2 diabetes are overweight and
obesity. Type 2 diabetes is the most common type of diabetes worldwide. It is
typically countered with changes in lifestyle activities such as improved diet
and increased physical activity. While insulin is rarely prescribed as the
initial drug for a type 2 diabetes patient, many of them may ultimately need it
to control blood glucose levels. Insulin patch pumps may work very well for
numerous patients suffering from type 2 diabetes.
The
development of patch pump technology has given an opportunity for improving the
quality of life of a broad demography of diabetes patients. The insulin patch
pump technology offers enhanced therapeutic benefits over traditional multiple
daily injection therapy. Currently available patch pumps are about the size of
a computer mouse which can be directly attached to the body without any tubing.
For the infusion of insulin, a small catheter is subcutaneously inserted from
the underside of the patch pump. The three main components of an insulin patch
pump are an insulin reservoir, a cannula and a pumping mechanism. Unlike
traditional pumps, these parts are contained in a single case without any
tubing. The device is directly worn on the body using an adhesive patch. The
activation of the patch is programmed from a remote device and the cannula is
inserted automatically.
Basal
insulin comprises of a majority of a person’s daily insulin requirement. It
offsets the liver’s glucose secretion into the bloodstream. Every few minutes,
the pancreas, in response to the liver’s secretion of glucose, secretes a small
amount of insulin in the bloodstream which is known as basal insulin. Before a
person develops diabetes, pancreas regularly produce insulin proportionate to
the amount of glucose present in the bloodstream. When there is a large amount
of blood glucose in the body, such as after meals, the pancreas secret larger
amounts of insulin known as bolus insulin. Using patch pumps, the rate of
insulin delivery can be adjusted in response to the liver’s pattern of glucose
secretion.
The major
factor responsible for the growth of insulin pump market is increasing
prevalence of diabetes. According to IDF, in 2015, diabetes affected 415
million people worldwide. This number is expected to reach up to 642 million by
2040.By 2040, 1 in 10 adults will have diabetes. With such rising incidence of
diabetes around the world, the demand for insulin patch pumps is expected to
increase favorably during the forecast period. As diabetic patients are
becoming increasingly aware about the technologically advanced alternatives to
control and manage diabetes, the insulin patch pump market will experience innovations
in the near future leading to development of new-age insulin patch pump systems
with enhanced insulin delivering capabilities.
Some of
the major players operating in the insulin patch pump marketare, Insulet Corporation, Debiotech S.A.,CeQur
SA, Unilife Corporation, Valeritas Holdings, Inc., Cellnovo Limited., EOFLOW
CO., LTD., Becton, Dickinson and Company.
Key Findings of the Research
Study:
·
Rising
incidence of diabetes around the world is expected to primarily drive the
growth of insulin patch pump market during the forecast period.
·
Insulin
patch pump provides an efficient alternative to traditional multiple injection
based insulin delivery systems.
·
Development
of insulin patch pumps by numerous players under pipeline will favorably
contribute to the market growth over coming few years.
·
North
America holds the major share of the insulin patch pump market due to the
commercial availability and rapid adoption of insulin patch pumps in the
region.
Insulin Patch Pump Market
Segmentation:
By
Type of Insulin:
- Basal
Insulin
- Bolus
Insulin
- Basal-Bolus
Insulin
By
End User:
- Hospitals
- Private clinics
- Online
pharmacies
- Retail
pharmacies
By Region:
o U.S
o Canada
o Mexico
o Germany
o France
o UK
o Italy
o Spain
o Rest
of Europe
o Japan
o China
o Australia
o India
o South
Korea
o Rest
of Asia Pacific
o Brazil
o South
Africa
o Saudi
Arabia
o United
Arab Emirates
o Others
Related Reports:
About Crystal Market Research
Crystal
Market Research is a U.S. based market research and business intelligence
company. Crystal offers one stop solution for market research, business
intelligence, and consulting services to help clients make more informed
decisions. It provides both syndicated as well as customized research studies
for its customers spread across the globe. The company offers market
intelligence reports across a broad range of industries including healthcare,
chemicals & materials, technology, automotive, and energy.
Contact:
Judy
304
South Jones Blvd, Suite 1896,
Las
Vegas NV 89107,
United
States
Toll
Free: +1-888-213-4282
